| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/17/2004 | CN1481794A Use for 3-indole aldehydes and its derivatives in preparation of anti-tumour medication |
| 03/17/2004 | CN1142274C Polypeptide having cell withering promoting activity |
| 03/17/2004 | CN1142183C Anti-idiotype microantibody and its preparing process and application |
| 03/17/2004 | CN1142181C Giant web bombinator polypeptide and its application for preparing anticancer and anti-AIDS medicines |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/17/2004 | CN1142155C Use of ampelopsin for preparing antileukemie and anti-nasopharyngeal carcinoma medicines |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1141975C Process for preparing xenogenous or autogenous tumor vaccine of liposome |
| 03/17/2004 | CN1141969C Medicine for treating dermatopathy |
| 03/17/2004 | CN1141944C Preparation method of leukemia treating medicine extracted from viscera of scallop |
| 03/16/2004 | US6706947 Method for screening for agents against cancer using an immunosuppression animal model |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706738 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706722 Heteroaryl derivatives and their use as medicaments |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706718 Potent inhibitors of cyclin dependent kinases; treating cancer or other proliferative diseases |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706708 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706491 Reagents and methods for identifying and modulating expression of genes regulated by p21 |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706265 Immunosuppressing graft rejection |
| 03/16/2004 | CA2294399C Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the treatment of cancer |
| 03/16/2004 | CA2190847C Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/16/2004 | CA2100709C Method and means for site directed therapy |
| 03/11/2004 | WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020624A1 Cancer antigens and utilization thereof |
| 03/11/2004 | WO2004020468A2 Interferon beta-like molecules for treatment of cancer |
| 03/11/2004 | WO2004020462A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | WO2004020461A1 A group of novel synthetic antibiotic peptides |
| 03/11/2004 | WO2004020460A1 Novel depsipeptide compound |
| 03/11/2004 | WO2004020440A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020434A1 Azaarene derivatives |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004020431A2 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2004020400A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019991A2 Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma |
| 03/11/2004 | WO2004019982A1 Remedy |
| 03/11/2004 | WO2004019973A1 Use of protein kinase n beta |
| 03/11/2004 | WO2004019961A1 Plant extracts for treatment of angiogenesis and metastasis |
| 03/11/2004 | WO2004019959A2 Dna repair enzymes |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2004019927A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 03/11/2004 | WO2004019912A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | WO2004019911A2 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 03/11/2004 | WO2004019910A2 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 03/11/2004 | WO2004019865A2 Amelioration of effects of cigarette smoke |
| 03/11/2004 | WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2004 | WO2004005279A3 Substituted anthranilic amide derivatives and methods of use |
| 03/11/2004 | WO2003106618A3 Cancer therapy by modulating cdc42-activity |
| 03/11/2004 | WO2003096782A3 Process for preparing maytansinol |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003088915A3 Novel sodium channel blockers |
| 03/11/2004 | WO2003084342A3 Method and dietary composition for improving lipid digestibility |
| 03/11/2004 | WO2003075899A3 Combinations comprising epothilone derivatives and alkylating agents |
| 03/11/2004 | WO2003068164A3 Dosing regimen for gemcitabine hcv therapy |
| 03/11/2004 | WO2003068162A3 Modified fluorinated nucleoside analogues |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003059395A3 Antisense compounds directed against human csf-1 |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003057838A3 Antibodies against the muc18 antigen |
| 03/11/2004 | WO2003057201A3 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003041736A3 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 03/11/2004 | WO2003039591A3 Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003009809A3 Cancer treatment with gö6976 and its related compounds |
| 03/11/2004 | WO2003006444A3 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 03/11/2004 | WO2003002060A3 Method of treating malignancy associated hypercalcemia using active vitamin d analogues |
| 03/11/2004 | WO2003000695A8 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002083074A3 Methods for the treatment of hepatic disorders |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049060 Process for the preparation of paclitaxel |
| 03/11/2004 | US20040049045 Process for the crystallization of (r)-or (s)-lansoprazole |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |